Fact-checked by Grok 2 weeks ago

Reticulocyte

A reticulocyte is an immature red blood cell that represents the penultimate stage in erythropoiesis, the process of red blood cell formation, characterized by residual ribosomal RNA that forms a visible reticular network when stained with supravital dyes such as new methylene blue.^[1] These cells are produced in the bone marrow from orthochromatic erythroblasts following nuclear extrusion and are released into the peripheral bloodstream, where they undergo final maturation into fully functional erythrocytes over 1 to 2 days.^[2] During this circulatory phase, reticulocytes lose organelles like mitochondria and ribosomes, remodel their plasma membrane by shedding exosomes, and reduce in size and volume by approximately 20%, adapting to their role in oxygen transport.^[3] Reticulocytes play a critical physiological role as indicators of bone marrow erythropoietic activity, reflecting the body's response to stimuli like hypoxia or anemia through increased production stimulated by erythropoietin (EPO).^[2] In healthy adults, reticulocytes constitute 0.5% to 2.5% of total circulating red blood cells, corresponding to a daily production rate sufficient to replace the normal lifespan of erythrocytes, which is about 120 days.^[4] Their enumeration via reticulocyte count—a simple blood test—provides diagnostic insight into erythropoiesis efficiency; elevated levels (reticulocytosis) signal compensatory responses to hemolytic anemias, acute blood loss, or recovery from marrow suppression, while low levels (reticulocytopenia) indicate hypoproliferative states such as aplastic anemia, nutritional deficiencies, or chemotherapy effects.^[1] The maturation process of reticulocytes involves dynamic cellular remodeling, including selective protein sorting, lipid reorganization, and clearance of unnecessary components to achieve the biconcave disc shape and flexibility essential for mature red blood cells.^[5] Abnormalities in reticulocyte maturation can contribute to disorders like hereditary spherocytosis or thalassemia, where defective membrane or hemoglobin synthesis leads to premature cell destruction.^[6] Clinically, monitoring reticulocyte indices, including hemoglobin content and maturity classification (e.g., early vs. late reticulocytes), enhances the assessment of anemia etiology and treatment efficacy, such as in EPO therapy or bone marrow transplantation.^[2]

Definition and Morphology

Definition

A reticulocyte is an immature erythrocyte, representing the penultimate stage in the development of red blood cells during erythropoiesis. Following the extrusion of the nucleus from orthochromatic normoblasts in the bone marrow, reticulocytes retain ribosomal RNA and polyribosomes, enabling continued synthesis of hemoglobin as they mature into fully functional erythrocytes within 1 to 2 days in the peripheral blood.^[2]^[1] The term "reticulocyte" derives from the Latin word reticulum, meaning "little net," which refers to the filamentous, mesh-like network of ribosomal RNA aggregates visible in the cytoplasm when these cells are stained with supravital dyes such as new methylene blue.^[2] In healthy adults, reticulocytes normally comprise 0.5% to 2.5% of the total red blood cell population in peripheral blood, reflecting a steady-state balance in erythropoiesis.^[4] This distinguishes reticulocytes from earlier nucleated precursors like normoblasts, which remain confined to the bone marrow, and from mature erythrocytes, which have fully degraded their RNA and ceased protein synthesis.

Morphology and Staining

Reticulocytes are enucleated cells, lacking a nucleus like mature erythrocytes, but they are distinguished by their retention of residual ribosomal RNA and other organelles, which contribute to their immature morphology.^[2] These cells measure approximately 8–10 μm in diameter, rendering them slightly larger than mature erythrocytes, which typically range from 6.7–7.7 μm.^[7] Their cytoplasm exhibits a polychromatophilic appearance under Romanowsky stains such as Wright's or Giemsa, appearing bluish-gray due to the basophilic ribosomal RNA interspersed with eosinophilic hemoglobin.^[8] The hallmark feature of reticulocytes is the reticular network formed by aggregated ribosomal RNA, visible only through supravital staining techniques that preserve cell viability.^[2] Common supravital stains include new methylene blue and brilliant cresyl blue, which bind specifically to the RNA, precipitating it into a blue-colored filamentous or granular network within the cytoplasm.^[2] This staining reveals the substantia granulofilamentosa, a mesh-like structure of ribosomes and mitochondria remnants, allowing microscopic differentiation from mature erythrocytes, which lack such inclusions.^[9] New methylene blue tends to produce deeper and more uniform staining of the reticulofilamentous material compared to brilliant cresyl blue, enhancing visibility of the network under light microscopy.^[10] In erythropoietic stress conditions, such as hemolytic anemia or acute blood loss, premature release of stress reticulocytes occurs, leading to morphological variations.^[2] These stress reticulocytes are notably larger than typical ones, often exceeding 10 μm in diameter, and display irregular, multilobular shapes due to accelerated maturation and skipped cell divisions in the bone marrow.^[11]^[12] Their cytoplasm may show denser basophilic stippling or more prominent granular inclusions upon supravital staining, reflecting higher residual RNA content.^[13]

Physiology and Development

Role in Erythropoiesis

Erythropoiesis, the process of red blood cell production, occurs primarily within the bone marrow and involves the progressive differentiation of hematopoietic stem cells into mature erythrocytes. This process begins with the proerythroblast stage, followed by basophilic, polychromatophilic, and orthochromatic erythroblast stages, leading to the formation of reticulocytes as the penultimate immature form.^[14] The terminal differentiation from proerythroblast to reticulocyte spans approximately 7 days in the bone marrow, during which the cells undergo multiple divisions and hemoglobin synthesis.^[14] Reticulocytes mark the final immature stage of erythropoiesis within the bone marrow, occupying the final 3-4 days of this 7-day timeline before their release into the peripheral circulation.^[15] As enucleated cells containing residual ribosomal RNA, reticulocytes are poised for the final maturation steps in the bloodstream, where they extrude organelles and remodel their membrane to optimize deformability and oxygen transport efficiency.^[5] This release ensures a steady supply of functional erythrocytes to maintain tissue oxygenation. The production and egress of reticulocytes are primarily regulated by erythropoietin (EPO), a glycoprotein hormone secreted mainly by peritubular fibroblasts in the kidneys in response to tissue hypoxia.^[16] EPO acts on erythroid progenitors from the colony-forming unit-erythroid stage onward, enhancing their proliferation, differentiation, and resistance to apoptosis, which accelerates reticulocyte output to counteract oxygen deficits.^[17] This feedback mechanism fine-tunes erythropoiesis to match physiological demands, with EPO levels rising during anemia or high-altitude exposure to boost reticulocyte release.^[18] In adults, reticulocytes originate from erythropoiesis in the red bone marrow, which is concentrated in the axial skeleton including the vertebrae, ribs, sternum, and proximal ends of the femur and humerus.^[18] This site supports the organized erythroblastic islands where central macrophages nurture developing erythroid cells. Under stress conditions such as severe hemolytic anemia, erythropoiesis can shift to extramedullary sites like the liver and spleen to increase reticulocyte production.^[18]

Maturation Process

Reticulocytes, released from the bone marrow as the penultimate stage in erythropoiesis, undergo a series of biochemical and structural transformations in the peripheral blood to become mature erythrocytes. This maturation process primarily occurs after their egress from the bone marrow, where nascent reticulocytes constitute approximately 20-25% of the red cell population but only about 1% of circulating red blood cells in peripheral blood.^[19]^[3] The transition reflects the rapid clearance of immature forms from the marrow to allow space for ongoing erythropoiesis while enabling final differentiation in circulation. The timeline for full maturation spans 1-2 days in human peripheral blood, during which reticulocytes progressively lose their residual RNA through degradation, leading to the condensation and stabilization of hemoglobin within the cytoplasm.^[3] Concurrently, cellular changes include the elimination of internal organelles such as mitochondria and ribosomes via autophagy-mediated processes, which purge unnecessary components to streamline the cell for oxygen transport.^[6] Surface remodeling accompanies these internal adjustments, involving the shedding of membrane vesicles that reduces the cell's surface area by about 20% and volume by 15%, resulting in the characteristic biconcave disc shape of mature erythrocytes.^[20] Maturation is influenced by key nutritional factors essential for hemoglobin synthesis, including iron availability, which supports heme production through transferrin receptor-mediated uptake, as well as folate and vitamin B12, which facilitate nucleic acid metabolism and prevent disruptions in protein assembly.^[6] Deficiencies in these elements can impair the efficiency of RNA degradation and organelle clearance, prolonging the reticulocyte stage.^[3]

Laboratory Assessment

Reticulocyte Count Methods

The manual method for reticulocyte counting involves preparing a peripheral blood smear using supravital staining with dyes such as new methylene blue or brilliant cresyl blue, which bind to ribosomal RNA in reticulocytes to produce a characteristic reticular network visible under light microscopy. Reticulocytes are then enumerated among a total of 1,000 red blood cells, with the count expressed as a percentage (normal range 0.5-2.5%) or converted to an absolute count by multiplying the percentage by the total red blood cell count (expressed as ×10^9/L). This approach, while cost-effective, is labor-intensive and subject to inter-observer variability due to subjective identification of reticulocytes based on their morphology. Automated methods, particularly flow cytometry, offer greater precision and throughput by analyzing thousands to tens of thousands of cells rapidly. In flow cytometry, blood samples are incubated with RNA-binding fluorescent dyes such as thiazole orange, which fluoresce upon binding to the residual RNA in reticulocytes, allowing discrimination from mature erythrocytes via laser excitation and detection of forward scatter and fluorescence signals. These systems provide both percentage and absolute reticulocyte counts, with improved reproducibility compared to manual techniques, as demonstrated by correlation coefficients exceeding 0.95 in validation studies. To account for anemia, which can artifactually elevate the reticulocyte percentage due to a reduced red blood cell denominator, the reticulocyte index is calculated as follows:

\text{Reticulocyte Index} = \left( \text{observed reticulocyte \%} \times \frac{\text{patient hematocrit}}{\text{normal hematocrit (45\%)}} \right) \div \text{maturation time}

where maturation time adjusts for early reticulocyte release in severe anemia (typically 1-2.5 days). This correction provides a more accurate assessment of bone marrow erythropoietic activity. Samples for reticulocyte counting require fresh whole blood collected in EDTA anticoagulant tubes to prevent clotting and maintain cell integrity, with analysis recommended within 24 hours to minimize artifactual decreases in reticulocyte counts due to RNA degradation or storage effects.

Immature Reticulocyte Fraction

The Immature Reticulocyte Fraction (IRF), measured using automated flow cytometers such as Sysmex analyzers, classifies reticulocytes into three subpopulations according to their RNA content and fluorescence intensity: the highly immature fraction (IRF-1 or high fluorescence reticulocytes [HFR], with high RNA), the moderately mature fraction (IRF-2 or medium fluorescence reticulocytes [MFR], with medium RNA), and the mature fraction (IRF-3 or low fluorescence reticulocytes [LFR], with low RNA).^[21] The IRF value specifically represents the proportion of the more immature subpopulations (IRF-1 and IRF-2) relative to the total reticulocyte count, serving as a refined measure of erythropoietic activity beyond basic quantification. In healthy adults, the IRF is normally 2.3-15.9%, while the total reticulocyte count typically ranges from 0.5% to 2.5%.^[22]^[4] An elevated IRF-1 fraction, in particular, signals an acute bone marrow response, as seen in early recovery phases following chemotherapy, where it reflects the preferential release of RNA-rich reticulocytes into circulation. The IRF provides advantages over standard reticulocyte counting by identifying shifts in bone marrow output 1-2 days earlier, particularly in dynamic scenarios such as acute blood loss, due to its sensitivity to the earliest immature forms. This subfractionation enhances the detection of erythropoietic changes in conditions requiring rapid assessment of marrow responsiveness.

Clinical Applications

Diagnostic Indications

Reticulocyte counts are a key diagnostic tool in evaluating anemias, particularly to distinguish between increased red blood cell destruction or loss and impaired bone marrow production. Elevated reticulocyte counts, known as reticulocytosis, typically indicate a compensatory response to hemolysis or blood loss, where the bone marrow ramps up erythropoiesis to replace lost red blood cells.^[4]^[23] In hemolytic anemias such as sickle cell disease or autoimmune hemolytic anemia, reticulocyte counts often exceed 2-3% of total red blood cells, reflecting ongoing red cell destruction and marrow hyperactivity.^[24]^[25] Similarly, acute blood loss or recovery from hemolysis prompts reticulocytosis, with counts rising within days to support hemoglobin restoration.^[26] Conversely, low reticulocyte counts, or reticulocytopenia, signal inadequate bone marrow production and are diagnostic for hypoproliferative anemias. In aplastic anemia, severe reticulocytopenia (often <1%) accompanies pancytopenia due to global marrow failure.^[27] Pure red cell aplasia presents with profound reticulocytopenia (<1%) and normocytic anemia, resulting from selective arrest of erythroid precursors while other cell lines remain unaffected.^[28]^[29] Marrow infiltration by malignancies, such as leukemia, can also cause reticulocytopenia by crowding out erythroid progenitors, leading to inappropriately low counts relative to the anemia severity.^[30] Ineffective erythropoiesis is identified when reticulocyte counts remain normal or low despite significant anemia, indicating intramedullary destruction of erythroid precursors rather than peripheral loss. This pattern is characteristic of disorders like β-thalassemia, where expanded but apoptotic erythroblasts fail to mature, resulting in mild reticulocytosis that underestimates the erythropoietic drive.^[31]^[32] In sideroblastic anemias, ineffective erythropoiesis similarly yields low or normal reticulocytes amid iron-laden ring sideroblasts, highlighting mitochondrial dysfunction in heme synthesis.^[33]^[34] Diagnostic interpretation must account for physiological variations, particularly in pediatrics and pregnancy. Newborns exhibit higher baseline reticulocyte counts of 3-7% at birth, which decline to adult levels (0.5-2.5%) within the first week as erythropoiesis stabilizes postnatally.^[35] In pregnancy, erythropoietin-driven reticulocytosis (up to 2-3%) supports the expanded red cell mass and plasma volume, though counts may normalize or decrease in iron-deficient states.^[36]^[37]

Monitoring and Prognosis

Reticulocyte parameters serve as key indicators for assessing response to therapeutic interventions in anemia management. In patients receiving erythropoietin (EPO) therapy, an increase in reticulocyte count typically occurs within days, signaling effective stimulation of erythropoiesis; for instance, studies have shown significant rises in reticulocyte counts following EPO administration in conditions like chronic kidney disease-associated anemia. Similarly, iron supplementation, particularly intravenous formulations combined with EPO, enhances reticulocyte production, with reticulocyte hemoglobin content rising as an early marker of iron incorporation into new red blood cells, often detectable within 48-96 hours of treatment initiation.^[36]^[38]^[39] Prognostic utility of reticulocyte indices extends to predicting outcomes in specific hematologic contexts. Persistent low immature reticulocyte fraction (IRF) values below 10% post-hematopoietic stem cell transplantation are associated with secondary graft failure, as observed in cases where neither IRF nor mean fluorescence intensity reached this threshold, indicating inadequate engraftment. In myelodysplastic syndromes (MDS), higher absolute reticulocyte counts (ARC ≥20 × 10⁹/L) correlate with improved overall survival (median 48 months versus 14 months for ARC <20 × 10⁹/L), serving as an independent marker of less severe ineffective erythropoiesis and better disease course.^[40]^[41] Serial monitoring of reticulocyte counts over days to weeks is essential for evaluating bone marrow recovery dynamics. Following chemotherapy for malignancies, reticulocyte parameters, including IRF, demonstrate trends of early hematopoietic rebound, often preceding platelet recovery by a median of 6 days and providing a reliable predictor of overall marrow regeneration. In post-hemorrhage scenarios, such as trauma-induced blood loss, rising reticulocyte counts within 3-4 days help track stabilization of hemoglobin levels and guide transfusion decisions by forecasting compensatory erythropoiesis.^[42]^[43] Despite their value, reticulocyte assessments have limitations that necessitate cautious interpretation. False elevations can occur post-splenectomy due to delayed clearance of immature red cells, leading to reticulocytosis without true increased production. Automated counts may also artifactually increase from interferences like autofluorescence or Heinz bodies, potentially misleading clinical evaluation. To mitigate these issues, corrected reticulocyte indices, accounting for hemoglobin levels, are recommended for accurate assessment of marrow function.^[44]^[45]^[46]

Research Directions

Pathophysiological Insights

Mutations in the transcription factor GATA1, essential for erythroid differentiation, disrupt normal erythropoiesis and lead to dyserythropoiesis characterized by ineffective red blood cell production and morphological abnormalities in erythroblasts, as observed in congenital dyserythropoietic anemia type X-linked forms.^[47] These molecular defects highlight how disruptions in key regulatory genes contribute to the pathogenesis of inherited anemias by halting terminal erythroid maturation at the reticulocyte stage. In hemoglobinopathies like sickle cell disease, reticulocytes experience heightened oxidative stress due to abnormal hemoglobin variants generating reactive oxygen species, which compromise membrane integrity and increase cellular fragility, thereby accelerating extravascular hemolysis.^[48] This oxidative damage exacerbates anemia by reducing reticulocyte survival in circulation and promoting inflammatory responses that further impair erythropoiesis.^[49] Post-2020 research has elucidated the role of microRNAs in reticulocyte maturation, with specific miRNAs such as miR-451 and miR-144-3p regulating gene expression to fine-tune hemoglobin synthesis and membrane remodeling during the transition to mature erythrocytes.^[50] These non-coding RNAs act post-transcriptionally to suppress targets involved in proliferation, ensuring orderly maturation, and their dysregulation is implicated in pathological delays observed in anemias. Single-cell RNA sequencing studies have further revealed significant heterogeneity among reticulocytes, identifying distinct subpopulations with varying transcriptional profiles related to stress responses and maturation states, which underscores the diversity in erythroid output under normal and disease conditions.^[51] Animal models have provided insights into reticulocyte export pathways from the bone marrow. In zebrafish, genetic manipulations disrupting erythropoietic regulators like etv7 demonstrate defects in erythroid cell export and maturation, revealing conserved mechanisms for reticulocyte release involving cytoskeletal dynamics and vascular interactions.^[52] Mouse knockouts of exportin 7 (Xpo7), an erythroid-specific nuclear export factor, impair the removal of nuclear proteins during enucleation and subsequent reticulocyte maturation, leading to accumulation of immature cells and highlighting the role of nuclear export in efficient erythropoiesis.^[53]

Emerging Therapies

Gene therapies targeting reticulocyte production represent a promising frontier in treating hemoglobinopathies like sickle cell disease (SCD). CRISPR-Cas9 editing of the beta-globin gene in hematopoietic stem cells (HSCs) corrects the underlying mutation, leading to the production of functional hemoglobin in maturing reticulocytes and reducing sickling upon deoxygenation. In preclinical models, reticulocytes derived from gene-edited HSCs exhibited significantly lower sickling rates (37% versus 63% in controls), thereby enhancing their quality and survival for effective oxygen delivery.^[54] Clinical trials, such as those evaluating exagamglogene autotemcel (exa-cel), have demonstrated sustained increases in fetal hemoglobin expression in reticulocytes post-infusion, alleviating vaso-occlusive crises in SCD patients.^[55] Novel erythropoiesis-stimulating agents, including hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) like roxadustat, offer long-acting alternatives to traditional EPO by stabilizing HIF to endogenously upregulate EPO production and iron metabolism, thereby boosting reticulocyte output in anemias associated with chronic kidney disease and other disorders. These agents have shown dose-dependent increases in reticulocyte counts and hemoglobin levels in phase III trials, providing weekly oral dosing with comparable efficacy to injectable ESAs but improved convenience.^[56] In paroxysmal nocturnal hemoglobinuria (PNH), complement inhibitors such as pegcetacoplan indirectly support reticulocyte maturation by mitigating extravascular hemolysis, allowing for normalized erythropoiesis without excessive reticulocytosis.^[57] Stem cell approaches utilizing induced pluripotent stem cells (iPSCs) aim to generate reticulocyte-like cells for transfusion medicine, addressing shortages in universal donor blood. Protocols for differentiating iPSCs into enucleated erythrocytes passing through reticulocyte stages have achieved high yields in scalable bioreactor systems, producing cells with functional oxygen-carrying capacity suitable for clinical use.^[58] Ongoing preclinical work focuses on optimizing maturation to mimic natural reticulocyte properties, potentially enabling off-the-shelf transfusions for patients with rare blood types or alloimmunization.^[59] As of 2025, phase III trials of luspatercept in myelodysplastic syndromes (MDS) have reported improved reticulocyte responses, with treated patients showing sustained increases in reticulocyte counts.^[60] In the COMMANDS trial, luspatercept achieved transfusion independence rates of 58.5% (vs. 31.2% with epoetin alfa), correlated with enhanced late-stage erythropoiesis as a TGF-β ligand trap, improving reticulocyte hemoglobin content and reducing transfusion burden in lower-risk MDS.^[61] These results underscore luspatercept's role in transforming anemia management by directly augmenting ineffective reticulocytopoiesis.

References

[1]
Reticulocytes - Clinical Methods - NCBI Bookshelf - NIH
Definition. Reticulocytes are the erythroid cells in the peripheral blood that are in a discrete, penultimate phase of maturation.Missing: function | Show results with:function
[2]
Histology, Reticulocytes - StatPearls - NCBI Bookshelf - NIH
May 19, 2023 · Function. A reticulocyte functions as a step in the process of erythropoiesis. It forms from a differentiated hematopoietic stem cell.[4] ...Missing: biology | Show results with:biology
[3]
Reticulocyte Maturation - PMC - PubMed Central - NIH
Mar 10, 2022 · In order to mature into RBCs, they must lose 20% of their plasma membrane, lose any residual organelles or internal membranes and selectively ...
[4]
Reticulocyte Count: Testing, Purpose & Results - Cleveland Clinic
Apr 18, 2022 · A reticulocyte count measures the number of immature red blood cells (reticulocytes) in your bone marrow.
[5]
The Shape Shifting Story of Reticulocyte Maturation - Frontiers
Jul 10, 2018 · Here we review the elusive last steps of reticulocyte maturation with an emphasis on protein sorting during the defining steps of reticulocyte formation.Abstract · Introduction · Enucleation · Maturation of Reticulocytes in...
[6]
Normal and disordered reticulocyte maturation - PMC
Reticulocytes undergo extensive membrane remodeling, volume changes, and eliminate all internal membrane-bound organelles and ribosomes.
[7]
Erythropoiesis: What It Is & Process Stages - Cleveland Clinic
Normoblast. Reticulocyte. Erythrocyte (fully mature red blood cell). Your bone marrow releases mature blood cells into your bloodstream. Once they're ...What Is Erythropoiesis? · What Causes Erythropoiesis? · What Is Erythropoietin?
[8]
Reticulocyte % | eClinpath
Reticulocytes are immature, anucleate erythrocytes which are released from bone marrow into the blood in increased numbers as a response to anemia.
[9]
Cellular dynamics of mammalian red blood cell production in the ...
The size of the reticulocytes is approximately 8–10 μm in humans and 6–8 μm in mice (Paul et al. 1973; Liu et al. 2010a). Reticulocytes exhibit reticular (net- ...
[10]
RBC precursors - Medpics - University of California San Diego
The cytoplasm is slightly purple due to residual RNA. These cells in the peripheral blood are called polychromatophilic RBCs; they are also reticulocytes (have ...
[11]
https://www.tandfonline.com/doi/pdf/10.1080/10245332.1998.11746388
[12]
Reticulocyte - an overview | ScienceDirect Topics
New methylene blue stains the reticulofilamentous material in reticulocytes more deeply and more uniformly than does brilliant cresyl blue, which varies from ...
[13]
Clinical Applications of Automated Reticulocyte Indices
The larger size of these "stress" reticulocytes was attribu- ted to the skipping of cell divisions in the bone marrow, due to the accelerated erythropoiesis and ...Missing: irregular | Show results with:irregular<|control11|><|separator|>
[14]
The Shape Shifting Story of Reticulocyte Maturation - PMC
Jul 11, 2018 · Healthy reticulocytes are 43 times more permeable to Ca2+ compared to mature erythrocytes ... Ex vivo large-scale generation of human red blood ...
[15]
Clinical Significance of Reticulocytes - IntechOpen
Very young reticulocytes called stress reticulocytes are released into the bloodstream in reaction to a severe case of anemia. Stress reticulocytes are ...Missing: irregular | Show results with:irregular
[16]
Erythroid maturation (erythropoiesis) - Pathology Outlines
Dec 13, 2021 · Erythropoiesis takes place within the bone marrow in ... Average time in the bone marrow from proerythroblast to reticulocyte is 7 days ...
[17]
[PDF] SEED HAEMATOLOGY - Sysmex Europe
As a rule, the reticulocyte remains in the bone marrow for a further three days and for one day in the peripheral blood- stream. The name 'reticulocyte' ...
[18]
Regulation of erythropoietin production - PMC - NIH
The O2 capacity of the blood increases with the enhanced release of reticulocytes. The role of extra-renal sites (brain, skin) in the control of the renal Epo ...
[19]
Erythropoiesis: insights into pathophysiology and treatments in 2017
Mar 23, 2018 · Erythropoiesis is a tightly-regulated and complex process originating in the bone marrow from a multipotent stem cell and terminating in a mature, enucleated ...
[20]
In vitro maturation of nascent reticulocytes to erythrocytes - PubMed
Mar 1, 2005 · Most studies of mammalian reticulocyte maturation have used blood reticulocytes. Nascent reticulocytes, as found in bone marrow ... 20% to 25% of ...
[21]
The ins and outs of reticulocyte maturation revisited - NIH
Apr 5, 2016 · The maturation of reticulocytes involves a reduction in cellular size and volume and the purging of residual membrane-bound organelles.
[22]
An easy way of performing reticulocyte count by manual method
It can be done by manual counting of the reticulocytes on a peripheral blood smear-stained with new methylene blue or by automated hematology cell counters.[1 , ...
[23]
Manual versus automated method for reticulocyte count
Conclusion: The study suggests that the manual method for reticulocyte count is as reliable as an automated method. Its cost-effectiveness and reliability are ...
[24]
Reticulocyte counting by flow cytometry. A comparison with manual ...
The automated method counts 10,000 cells or more vs. 1,000 cells counted by the manual method. Although inherently more precise, the FACS method may be ...
[25]
Reticulocyte count using thiazole orange. A flow cytometry method
Thiazole orange, a fluorochrome, is used with flow cytometry to discriminate reticulocytes. It is a fast, reliable method for routine clinical quantitation.
[26]
Flow cytometric reticulocyte counting: a comparison between ... - NIH
The peripheral reticulocyte count is commonly used as an indicator of the erythropoietic activity of the bone marrow. Manual counting provides results with ...
[27]
Reticulocyte Index - an overview | ScienceDirect Topics
It is calculated using the formula: RI = Reticulocytes percentage (%) × Ht (%) Normal Ht (%), where a low RI indicates inadequate marrow response and a high RI ...
[28]
Reticulocyte count: a simple test but tricky interpretation! - PMC - NIH
Its normal fraction in the blood is low (0.5% to 2.5% in adults and 2% to 6% in infants) because there is a homeostasis between destruction of aged abnormal RBC ...
[29]
005280: Reticulocyte Count - Labcorp
... reticulocyte counting technology. Specimen Requirements. Specimen. Whole blood. Volume. Tube fill capacity. Minimum Volume. 500 μL for Microtainer™ (capillary) ...
[30]
Reticulocyte Count and Reticulocyte Hemoglobin Content
Sep 25, 2025 · Normal ARC in infants older than 3 months and adults is ~ 25,000-75,000/μL (1.0 ± 0.5% of 5 million RBCs/μL). ARC is useful in the ...
[31]
Peripheral blood reticulocytes and their reference range values for ...
The HFR fraction is made up of the youngest reticulocytes. The sum of the HFR and MFR fractions is known as the immature reticulocyte fraction (IRF) [2, 3] .
[32]
Clinical utility of immature reticulocyte fraction for identifying early ...
This study assessed the value of immature reticulocyte fraction (IRF) in differentiating preregenerative anemia (PRA) from nonregenerative anemia (NRA) in dogs.
[33]
Clinical significance of immature reticulocyte fraction ... - PubMed
Our results indicate that an IRF of 0.23 or less in patients with anemia reflects bone marrow that is nonresponsive or underresponsive to the anemia.
[34]
Diagnosis of hemolytic anemia in adults - UpToDate
Aug 1, 2025 · - High reticulocyte count · - High LDH and bilirubin; low haptoglobin · Immediate management before the cause is identified · Post-diagnostic ...
[35]
Anemia - StatPearls - NCBI Bookshelf - NIH
Aug 8, 2023 · But, if the reticulocyte count is > 2%, hemolytic anemia should be considered. ... Hemolytic anemia: Diagnosis and treatment]. Nihon Naika ...
[36]
Anemia - Knowledge @ AMBOSS
Sep 11, 2025 · Normocytic anemia: Measure retic count to assess bone marrow response. Retic count > 2%: reassess history for blood loss and consider FOBT for ...Hemolytic anemia · Autoimmune hemolytic anemia · Iron deficiency
[37]
Reticulocyte Count - an overview | ScienceDirect Topics
An elevated reticulocyte count suggests chronic blood loss or hemolysis; a normal or depressed count suggests impaired red cell formation. The reticulocyte ...
[38]
Aplastic Anemia and Pure Red Cell Aplasia (PRCA) - DynaMed
Mar 17, 2025 · ... anemia with severe reticulocytopenia and significant reduction or absence of erythroid precursors in bone marrow. 4. Types. aplastic anemia.Missing: indications | Show results with:indications
[39]
How I manage acquired pure red cell aplasia in adults | Blood
Apr 15, 2021 · Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by malproductive, reticulocytopenic, normocytic anemia and the disappearance of ...Missing: indications | Show results with:indications
[40]
Recommendations on haematological criteria for the diagnosis of ...
Nov 2, 2004 · Current standard diagnostic criteria for pure red cell aplasia. • Fall in red cell count of about 1%/d. • Reticulocyte count below 1%. • No ...
[41]
Evaluation of Anemia - Hematology and Oncology - Merck Manuals
Nov 20, 2014 · For example, higher values indicate compensatory production (reticulocytosis); in the presence of anemia, reticulocytosis suggests excessive RBC ...
[42]
Ineffective erythropoiesis and its treatment | Blood - ASH Publications
A number of studies showed that this component increases considerably in patients with megaloblastic anemia, β-thalassemia, and sideroblastic anemia.6,9 The ...
[43]
Ineffective Erythropoiesis - The Blood Project
Aug 29, 2025 · Ineffective erythropoiesis (IE) is the hallmark of thalassemia. Unlike hemolysis or blood loss, where red cells are destroyed or lost after ...
[44]
Sideroblastic Anemia - StatPearls - NCBI Bookshelf - NIH
Dec 11, 2024 · Sideroblastic anemia is characterized by impaired iron utilization during erythropoiesis, leading to ring sideroblasts in the bone marrow.
[45]
Ineffective Erythropoiesis - an overview | ScienceDirect Topics
In these patients, there is anemia and an inappropriately low reticulocyte count, accompanied by high EPO levels, erythroid marrow hyperplasia, and laboratory ...
[46]
Reticulocyte Count - an overview | ScienceDirect Topics
... immature reticulocyte fraction (IRF). In individuals with anemia, the ... Beckman Coulter, which relates to the volume of erythrocytes and reticulocytes.
[47]
Erythropoietin increases reticulocyte counts and maintains ... - NIH
We found that administering Epo to these neonates significantly increased reticulocyte counts and maintained hematocrit, despite phlebotomy losses that trended ...<|control11|><|separator|>
[48]
Reticulocyte count - UCSF Benioff Children's Hospitals
Nov 3, 2024 · Reticulocytes are slightly immature red blood cells. A reticulocyte count is a blood test that measures the amount of these cells in the blood.
[49]
The effect of intravenous iron on the reticulocyte response ... - PubMed
We studied the effect of intravenous (iv) administration of 200 mg of iron sucrose following an iv bolus injection of recombinant human erythropoietin (r-HuEPO)Missing: supplementation | Show results with:supplementation
[50]
Reticulocyte and Erythrocyte Hemoglobin Parameters for Iron ... - NIH
Sep 19, 2021 · As iron demand is high and there is no present need to store iron, reticulocyte hemoglobin can track the response to iron repletion therapy ...
[51]
https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.828700/full
[52]
Severe ineffective erythropoiesis discriminates prognosis in ...
Aug 14, 2020 · Subject terms: Myelodysplastic syndrome, Prognosis. Introduction ... MDS myelodysplastic syndrome, ARC absolute reticulocyte count, MDS ...
[53]
Assessment of Hematological Recovery by Reticulocyte Parameters ...
Jul 30, 2025 · At the end of the study out of 50 cases, Ret% and Abs ret count showed early recovery in a median of 6 days before the platelet count recovery ...
[54]
Reticulocyte counts and their relation to hemoglobin levels in trauma ...
The measurement of reticulocytes may be helpful in predicting the recovery in Hb after acute blood loss due to trauma and to assist in deciding whether a ...Missing: stabilization | Show results with:stabilization
[55]
Reticulocyte crisis after splenectomy: evidence for delayed red cell ...
Immediately after splenectomy (n = 4), a reticulocytosis is observed, mainly manifest in the top fractions (262.0 +/- 49.0% versus 40.0 +/- 32.4% preoperatively ...
[56]
Detecting Erroneous Blood Counts - Blood Cells - Wiley Online Library
Nov 14, 2014 · Automated reticulocyte counts may be falsely elevated when there is autofluorescence or when fluorescence is produced by binding of the ...
[57]
(PDF) Heinz bodies interfere with automated reticulocyte count
Aug 6, 2025 · They can cause erroneously high total white blood cell counts and an increase in MCHC and MCH, but there is no evidence of artificial elevation ...
[58]
Congenital anemia reveals distinct targeting mechanisms for master ...
Apr 21, 2022 · We noted that the GATA1 R307C/H mutations partially disrupted a predicted nuclear localization signal55 and observed that this mutation resulted ...
[59]
Targeting EPO and EPO RECEPTOR PATHWAYS in Anemia and ...
Potential high merit therefore exists for defining new targets for anti-anemia agents within EPO, and EPO receptor (EPOR) regulatory circuits.
[60]
Oxidative Stress in Healthy and Pathological Red Blood Cells - PMC
Aug 18, 2023 · The repeated cycles of HbS polymerization induce RBCs' shape distortion, cell rigidity, cell membrane alteration, and fragility, ultimately ...
[61]
The Role of RBC Oxidative Stress in Sickle Cell Disease
In SCD, the sickle RBCs are the root cause of the disease and they are a primary source of oxidative stress since sickle RBC redox state is compromised.
[62]
Red Blood Cells as MicroRNA Repositories in Circulation
Jun 2, 2020 · This review discusses the potential roles of RBC miRNAs under physiological and pathological conditions, as well as possible mechanisms by which these function.
[63]
Single Cell RNA-Seq Analysis of Human Red Cells - Frontiers
Apr 19, 2022 · In this study, we have established that single RBC RNA-Seq can be used to identify heterogeneity among RBCs with seven distinct cell clusters.
[64]
Using the Zebrafish as a Genetic Model to Study Erythropoiesis - PMC
The differentiation process between CFU-Es and reticulocytes, called terminal erythropoiesis, involves production of vast amounts of hemoglobin, nuclear ...
[65]
An in vivo model for elucidating the role of an erythroid-specific ... - NIH
Aug 13, 2022 · Xpo7A knockout mice were born in normal Mendelian ratios, showed no anemia in adults, and had no impaired response to stress erythropoiesis ...
[66]
Recent advancements in gene therapy for sickle cell disease and β ...
In this review article, we discuss the current genetic approaches and innovative strategies to ensure safe and effective gene therapy for SCD and β-thalassemia.
[67]
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat ...
Aug 30, 2023 · CRISPR-Cas9 disruption of the HBG1 and HBG2 gene promoters was an effective strategy for induction of fetal hemoglobin.<|control11|><|separator|>
[68]
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in ...
Apr 4, 2024 · Roxadustat was the first-in-class HIF-PHi approved for treatment of anaemia in patients with DD-CKD and NDD-CKD and is the most studied globally ...Treatment Of Anaemia In Ckd... · Approved Hif-Phis · Suggestions For Clinical...Missing: reticulocyte | Show results with:reticulocyte<|control11|><|separator|>
[69]
Pegcetacoplan in paroxysmal nocturnal hemoglobinuria - NIH
Aug 7, 2022 · Change in absolute reticulocyte count. Absolute reticulocyte count decreased in all patients receiving pegcetacoplan. In the study by de ...
[70]
https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202504725
[71]
the emerging potential of induced pluripotent stem cells (iPSCs) - NIH
Dec 26, 2024 · In general, iPSCs provide a promising solution to ESCs regarding ethical and societal concerns. iPSCs can produce erythrocytes for transfusion ...
[72]
Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients ...
Nov 5, 2020 · Luspatercept-mediated CB (RBC-TI ≥ 8 weeks and/or mHI-E) was associated with increased blood reticulocyte counts and was higher in pts with ...
[73]
Long-Term Transfusion Independence with Luspatercept Versus ...
May 16, 2025 · Luspatercept achieved significantly greater rates of red blood cell (RBC) transfusion independence (TI) versus epoetin alfa (an ESA) in the phase 3 COMMANDS ...Missing: reticulocyte | Show results with:reticulocyte